Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for agitation during awakening after hip replacement in elderly patients
ChiCTR2300068101Phase 4Not yet recruiting
- Sponsor
- Anqing Municipal Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative delirium (POD) comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Incidence of agitation during the waking period. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300068101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068101.